A multicenter, double-blind, placebo-controlled study conducted over 2 years enrolled 303 patients ages 18 to 55 years with recent CIS suggestive of MS. Disease activity was observed in a smaller ...

Optic nerve involvement is common among patients presenting with CIS of MS. Adding the optic nerve as a fifth site for dissemination in space fulfillment increases the sensitivity, decreases the ...

January 30, 2010 — Tears may one day replace cerebrospinal fluid in diagnosing multiple sclerosis, report researchers. The new isoelectric focusing technique detects oligoclonal bands in eye fluid and ...

Radiologically isolated syndrome (RIS) involves MS-like lesions on MRI without clinical symptoms, with a significant risk of progression to MS. Updated 2023 RIS criteria improve diagnostic accuracy, ...

Treatment of clinically isolated syndrome with oral cladribine improves clinical outcomes roughly a decade later, slowing progression to clinically definite multiple sclerosis (MS) and reducing ...

Teriflunomide treatment incurred an unadjusted risk reduction of 63% and an adjusted risk reduction of 72% in inhibiting a first clinical demyelinating event in patients with multiple sclerosis (MS).

Briumvi (ublituximab-xiiy) is a brand-name solution for intravenous infusion prescribed for certain forms of multiple sclerosis and clinically isolated syndrome in adults. As with other drugs, Briumvi ...